2 results
Approved WMOCompleted
To gain information about the characteristics of the oVEMP response in patients with BRIC type 1
Approved WMORecruiting
Primary objectiveThe primary objective of this study is to confirm non-inferiority of once-weekly somapacitan compared with once-daily Norditropin® in terms of longitudinal growth measured by height velocity at week 52 in children with each of the…